{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Leucovorin Calcium is an injectable prescription drug, a folate analog, used to reduce toxicity from certain chemotherapy medications. It comes as a lyophilized powder for solution, administered intramuscularly or intravenously, with each vial containing 100 mg of leucovorin calcium. Manufactured by BluePoint Laboratories under ANDA089717. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Leucovorin calcium \u2014 ANDA 213929 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213929", "mediaType": "text/html", "title": "Leucovorin calcium"}], "identifier": "ANDA213929", "issued": "2016-09-16", "keyword": ["drug", "drug-information", "drug-manufacturers", "health-care", "public-health"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Leucovorin calcium"}